Rocket Science Health US Corp.
Develops investigational intranasal drug delivery technologies that target the olfactory region to enable direct-to-brain delivery. The organization combines fluidics engineering, human factors design, preclinical and in-human testing, biomarker sampling, and delivery-verification software. The company pursues partnerships and licensing with CDMOs and pharmaceutical developers and holds issued U.S. patents covering methods and devices for precision intranasal delivery.
Industries
N/A
Products
Investigational olfactory‑targeting intranasal device
A needle-free, self-guided intranasal device engineered to position a dispensing tip past the nasal valve and eject a laminar liquid stream for targeted delivery to olfactory subregions.
Investigational olfactory‑targeting intranasal device
A needle-free, self-guided intranasal device engineered to position a dispensing tip past the nasal valve and eject a laminar liquid stream for targeted delivery to olfactory subregions.
Services
Licensing and technology partnerships for intranasal delivery
Non-exclusive licensing and partner identification for device integration, clinical development, and commercialization with pharmaceutical and biotech developers.
Human factors and usability evaluation
Formative and evaluative human factors studies to validate device fit, comfort, and intuitive operation across diverse nasal anatomies and user abilities.
Integrated biomarker sampling and delivery verification
Integration of biomarker diagnostics and software tools to support proof-of-delivery and therapy monitoring alongside device use.
Licensing and technology partnerships for intranasal delivery
Non-exclusive licensing and partner identification for device integration, clinical development, and commercialization with pharmaceutical and biotech developers.
Human factors and usability evaluation
Formative and evaluative human factors studies to validate device fit, comfort, and intuitive operation across diverse nasal anatomies and user abilities.
Integrated biomarker sampling and delivery verification
Integration of biomarker diagnostics and software tools to support proof-of-delivery and therapy monitoring alongside device use.
Expertise Areas
- Intranasal drug delivery
- Direct-to-brain (olfactory) delivery
- Fluidics engineering for medical devices
- Human factors and usability testing
Key Technologies
- Laminar fluid ejection (LFE)
- Olfactory‑targeting intranasal device geometry
- 3D-printed nasal anatomical models
- Preclinical PET imaging